pharmaphorum

JULY 14, 2022

The legacy product now lies outside Bayer’s core areas of cardiology, oncology, haematology, ophthalmology, women’s health and radiopharmaceuticals, and the funds raised from the sale will support the “ongoing transformation of Bayer’s pharma business to focus on key areas of future medical innovation”, said the company.

Drugs 88

Drugs Sales Pharma Companies Cardiology 88

BioTech 365

OCTOBER 15, 2020

ISTANBUL–(BUSINESS WIRE)– Company name: Er-Kim Ilac Presentative: Cem Zorlular, CEO AnGes, Inc.,

Pharma Companies 40

Pharma Companies Licensing Licensing Gene 40

pharmaphorum

MAY 4, 2022

As the technology advances further, it could become possible to harness a patient’s stem cells to create a personalised organ-on-a-chip, offering further potential to create a specific treatment for an individual – the definition of a personalised medicine. Nascent technology.

Drugs 143

Drugs Licensing Licensing Pharma Companies 143

pharmaphorum

FEBRUARY 11, 2022

Ipsen has started exclusive negotiations that could see its global consumer health business sold to fellow French pharma company Mayoly Spindler later this year. billion takeover of Clementia Pharma in 2019. billion of its revenues last year.

Sales 92

Sales Pharma Companies Branding Cosmetics 92

pharmaphorum

OCTOBER 28, 2020

Claus Møldrup explores research showing that patients want their voice to be heard more by pharma, and asks what a truly effective feedback loop for medicines might look like. Pharma remains stubbornly closed to feedback, with potentially damaging consequences for the industry, healthcare systems and patients.

Medicine 119

Medicine Pharma Companies Vaccination Vaccine 119

pharmaphorum

NOVEMBER 29, 2021

It was billed at the time as a key tool to accelerate the development of new and innovative vaccines to combat some of the world’s most prevalent diseases, from discovery to licensed product.

Vaccination 97

Vaccination Vaccine Manufacturing Pharma Companies 97

pharmaphorum

JANUARY 8, 2021

There’s a new player in the neurology and mental health drugs market after Italy’s Angelini Pharma merged with Switzerland’s Arvelle Therapeutics in a deal worth up to $960 million based around the anti-seizure drug cenobamate. Revenue share payments due to certain of the Arvelle shareholders will be assumed by Angelini Pharma.

Licensing 52

Licensing Licensing Pharma Companies Branding 52

pharmaphorum

JANUARY 24, 2023

The collaboration takes CytoReason’s partnering with leading pharmaceutical companies to a total of five. Through use of precision medicine and machine learning (ML), the company’s cell-centred models will aid identification of patient subtypes and pair them with personalised IBD targets. Image source: Kindel Media on Pexels.

Medicine 52

Medicine Drugs Pharma Companies Clinical Trials 52

pharmaphorum

FEBRUARY 13, 2022

If all goes to plan, Merck has the option to obtain up to a five-year exclusive license to use of BioAI in a specific disease domain, which would result in an undisclosed payment to the Israeli startup. “If successful, this could lead to a much-needed transformation in drug development speed, safety and cost,” said Ciechanover.

Drugs 98

Drugs In-Vivo In-Vitro Pharma Companies 98

Camargo

NOVEMBER 11, 2020

Unpacking the (Black) Box: Antares Licenses Urology Product with Boxed Warning. In October, Antares Pharma licensed Ferring Pharmaceuticals’ Nocdurna® (desmopressin acetate) sublingual tablet , which was approved in 2018 for the same indication as Noctiva and has a boxed warning highlighting the same risks.

Development 242

Development Bioequivalency Generic Drugs Production 242

pharmaphorum

JANUARY 7, 2022

If the last couple of days is an indication, 2022 is already shaping up to be the year of big-ticket alliances between big pharma companies and specialists in artificial intelligence-driven discovery. Shortly after Amgen unveiled its $1.9

Drugs 104

Drugs Pharma Companies Medicine Licensing 104

pharmaphorum

APRIL 22, 2021

Although the company has no agreements in place to acquire any companies, or license in any drugs, Centessa is interested in exploring such opportunities if they arise. The company has an “asset focused” R&D philosophy , where development is centred on the needs of each individual biotech.

Licensing 54

Licensing Licensing Pharma Companies Drugs 54

Fossil Remedies

NOVEMBER 22, 2022

You can become part of a big company network as a PCD pharma distributor or a PCD pharma firm. Other than conventional medicines, nowadays, people are making good money by opening franchises in Neuro products, Ayurvedic medicines, Gynec products, etc. Wide range of products. Pricing strategy.

Branding 52

Branding Pharma Production Production Marketing 52

pharmaphorum

NOVEMBER 30, 2022

The question is, how can the journey there be accelerated, when on the horizon awaits a life sciences future very much immersed in speciality medicine? The biggest gathering of pharma companies in Europe right now on the commercial side, the Veeva Systems Summit permits the sharing of best practices and of new ideas.

Life Science 97

Life Science Pharma Companies Sales Marketing 97

pharmaphorum

DECEMBER 9, 2022

Sanofi has walked away from a four-year-old partnership with Revolution Medicines focused on an SHP2 inhibitor, intended as a combination with KRAS inhibitors, including Sanofi’s Mirati-partnered adagrasib.

Pharma Companies 59

Pharma Companies Licensing Licensing Trials 59

pharmaphorum

MAY 13, 2022

According to BridgeBio and other SHP2 developers like Revolution Medicines, Jacobio, Erasca, Redx Pharma and Relay Therapeutics, the phosphatase enzyme – once considered “undruggable” – is over-expressed in a number of different solid tumour types.

Drugs 59

Drugs Pharma Companies Licensing Licensing 59

pharmaphorum

JUNE 4, 2021

The technology behind the drug was licensed from Weill Cornell Medicine and Johns Hopkins University in the US. ” The deal – financial terms of which were not disclosed – comes against a backdrop of increasing interest in radionuclide drugs among pharma companies.

Antibody 61

Antibody Licensing Licensing Protein 61

pharmaphorum

OCTOBER 7, 2021

The factory will be able to supply up to 500 million doses of mRNA shots a year, and cover the full spectrum of manufacturing from drug substance production through to full/finish and packaging, according to the company. According to the latest WHO data, just 4.4%

Vaccination 93

Vaccination Vaccine Manufacturing Packaging 93

XTalks

AUGUST 21, 2023

“The FDA approval of Sohonos is a breakthrough for the US FOP community,” said Howard Mayer, head of R&D at Ipsen, in the company’s news release. Development of medicines for rare diseases takes commitment and belief from everyone involved.

Drugs 98

Drugs FDA Approval Genetics Clinical Trials 98

pharmaphorum

FEBRUARY 12, 2021

This important transaction will further position Sandoz as a global leader in antibiotics – truly essential medicines that are the backbone of modern healthcare systems,” said the company’s chief executive Richard Saynor.

Drugs 110

Drugs Sales Pharma Companies Marketing 110

pharmaphorum

FEBRUARY 15, 2022

Lilly originally agreed paid $20 million upfront for a license to the maytansinoid technology in 2011, and expanded the partnership two years later, only to exit the agreement in 2018. Lilly is thought to be the first pharma company to sign up to use the new camptothecin payload platform.

Antibody 52

Antibody Licensing Licensing Drugs 52

pharmaphorum

JUNE 11, 2021

Ocugen is the first company to be affected by the FDA’s recent decision to raise the bar on emergency use authorisations for COVID-19 medicines, and will have to file for full approval of its vaccine candidate. Bharat has also reported data suggesting the shot is effective against the beta (B.1.351) 1.351) variant.

Vaccination 62

Vaccination Vaccine Clinical Trials Clinical Trials 62

pharmaphorum

MAY 27, 2022

This is the second in a two-part series examining how pharma can embrace the DEI agenda to create more effective medicines through more representative clinical trials. There is a huge opportunity for pharma companies to capitalise on by focusing on increased DEI in clinical trials. What comes next? About the interviewees.

Clinical Trials 80

Clinical Trials Clinical Trials Trials Packaging 80

pharmaphorum

SEPTEMBER 18, 2020

But although it was dubbed a “dangerous game”, some companies came out on top… On 6th April 1999, two companies with similar science-based cultures and a shared vision of the pharmaceutical industry came together to form what’s now considered as one of the top ten pharma companies in the world: AstraZeneca.

Pharma Companies 116

Pharma Companies Sales Vaccination Vaccine 116

Fossil Remedies

APRIL 26, 2022

PCD Pharma Business Plan. In a pharmaceutical business, you need a link between the pharma marketing company and the end-user, i.e., doctors, pharmacists, or others who can prescribe the medicine. This connecting link is the PCD Pharma Business. The Drug License Number and GST Number are these two documents.

Doctors 59

Doctors Doctor Marketing Production 59

pharmaphorum

MARCH 26, 2021

The UK Government and EU Commission trumpeted their Brexit trade deal, struck at the end of December, as ‘comprehensive’, the ‘biggest yet’ But a closer inspection of the EU-UK Trade and Cooperation Agreement (TCA) renders these statements largely illusory for the pharma sector. Medical devices do not feature at all.

Production 101

Production Medicine Marketing Regulation 101

Camargo

SEPTEMBER 23, 2020

The amount of interest and investment in rare diseases and orphan drugs has grown tremendously in recent years, leading to continuous innovation in a space that was once largely overlooked.

Business Development 136

Business Development Drugs Development Production 136

pharmaphorum

NOVEMBER 23, 2022

uniQure and CSL have become the first pharma companies to get regulatory approval for a gene therapy for haemophilia B anywhere in the world, after the FDA cleared their Hemgenix therapy for adults with the bleeding disorder in the US. million – making it the most expensive medicine in the world. That is well above the $2.9

Gene Therapy 59

Gene Therapy Gene FDA Approval Trials 59

pharmaphorum

DECEMBER 21, 2020

Compared with many of the established names in pharma these companies are young upstarts but they have managed to achieve what other big names in the industry have failed to do and harness the power of mRNA to make medicine. This will revolutionise medicine over the next 10-15 years in areas we do not even imagine.”.

Vaccination 90

Vaccination Vaccine Doctors Doctor 90

Drug Discovery World

MARCH 29, 2023

An example of the current disparity, drawn from data from the European Federation of Pharmaceutical Industries and Associations (EFPIA), can be seen in Romania, Poland or Bulgaria, where a recently approved medicine will take more than 800 days on average before it becomes publicly available compared with Germany, where that figure is 133 days 3.

Clinical Trials 52

Clinical Trials Clinical Trials Production Medicine 52

Delveinsight

AUGUST 2, 2020

Helsinn Group , a Swiss pharma player, is evaluating Anamorelin, an orally active selective ghrelin receptor agonist against Cancer cachexia, The company is conducting Phase III trial to test the efficacy and safety of anamorelin for the treatment of weight loss and anorexia in patients with advanced NSCLC with cachexia.

Marketing 94

Marketing Pharma Companies Development Hormones 94

Pharmaceutical Technology

MARCH 31, 2023

On March 30, ViiV Healthcare and Medicines Patent Pool (MPP), announced sublicensing agreements with the pharma manufacturers Aurobindo , Cipla and Viatris to produce generic forms of the long-acting cabotegravir used as pre-exposure prophylaxis (PrEP) for HIV.

Medicine 130

Medicine Manufacturing Pharma Companies Licensing 130

pharmaphorum

DECEMBER 16, 2022

She continued to say that the stockpiling of vaccines and treatments in richer nations had left other nations without access to lifesaving medicine. This could mean that the pharma companies would need to disclose pricing and contractual terms for pandemic products, as well as mechanisms to transfer technology and expertise.

Vaccination 86

Vaccination Vaccine Production Licensing 86

pharmaphorum

AUGUST 25, 2021

It’s now globally accessible due to Gilead’s work with a network of generic manufacturers and their ability to sign licensing agreements just days after the US FDA registered its authorisation. We went back to what we do best … we engaged our network of companies. It’s not a coincidence that we now have over 2.3

Marketing 52

Marketing Licensing Licensing Manufacturing 52

pharmaphorum

MAY 14, 2021

Read below for a preview: One of the earliest and most pronounced impacts of the UK’s vote to leave the European Union was the loss of the European Medicines Agency (EMA). NICE has always been a great reference in HTA for cost-effectiveness analysis (CEA) and cost-utility analysis (CUA) of new medicines,” he says. appeared first on.

Marketing 59

Marketing Regulation Medicine Life Science 59

pharmaphorum

JANUARY 12, 2021

While there are RNAi products on the marketplace, with Alnylam becoming the first company to get a product approved in 2018, it is difficult to get this class of drug distributed through the brain and spinal cord.

RNA 82

RNA Production Development Pharma Companies 82

pharmaphorum

APRIL 19, 2022

RudaCure is a four-year-old biotech company based in the South Korea, focusing on ocular disease and chronic pain with a pair of potentially first-in-class drugs. The company recently raised $16.5 The company’s second drug candidate, RCI002, is focused on chronic pain. Everyone in our team is very valuable,” he said.

Marketing 52

Marketing Clinical Trials Clinical Trials Licensing 52